Numerous studies have suggested the expression level of the CYP24A1 was abnormally increased in several cancers, such as breast cancer, ovarian cancer, cervix carcinoma, lung cancer, and colon cancer [7, 37, 38]. Here, CYP24A1 is linked to malignant colon neoplasm.